Pharmafile Logo
Pharmafocus logo
Advanced Search
astrazeneca_sign_sky

Two CHMP recommendations for AstraZeneca: Imfinzi in first-line lung cancer, Calquence in chronic lymphocytic leukaemia

July 27, 2020
Sales and Marketing AstraZeneca, CHMP, Calquence, EMA, Imfinzi

AstraZeneca has secured two new recommendations for approval of its products from the European Medicines Agency’s Committee for Medicinal Products …

News
glenmark

Glenmark’s favipiravir accelerates viral clearance and clinical recovery in COVID-19 patients

July 24, 2020
Medical Communications, Research and Development COVID-19, coronavirus, favipiravir; Glenmark

The antiviral treatment favipiravir, in development from Glenmark Pharma, has shown promise as a potential COVID-19 therapy after hitting its …

News
indianapolis

Eli Lilly asks for a $24 million tax break for diabetes care facility expansion in Indianapolis

July 24, 2020
Medical Communications Eli Lilly, Humalog, diabetes, insulin

Insulin manufacturer Eli Lilly has requested a $24 million tax break over the next 10 years as an investment into …

News

UCB’s investigational IL-17A and IL-17F inhibitor outclasses Novartis’ Cosentyx in plaque psoriasis

July 24, 2020
Medical Communications, Research and Development Cosentyx, UCB, pharma, psoriasis

UCB has revealed promising new data from a head-to-head trial pitting the company’s IL-17A and IL-17F inhibitor bimekizumab against Novartis’ …

News
stsock_frugu

Brazilian study finds hydroxychloroquine is not effective at treating COVID-19

July 24, 2020
Medical Communications COVID-19, coronavirus, hydroxychloroquine, pandemic

Another study has shown hydroxychloroquine is ineffective in treating the coronavirus. The research was published in the New England Journal …

News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

July 24, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10, top 10 stories

As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for …

News
meekey

David Meeker appointed Chief Executive Officer of Rhythm Pharmaceuticals

July 23, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Rhythm Pharmaceuticals have appointed David Meeker, M.D., as its Chief Executive Officer and President of the company. Meeker succeeds interim …

Appointment
big_mac

Biogen appoints Michael McDonnell as Chief Financial Officer and Executive Vice President

July 23, 2020
Business Services

Biogen have announced that they have appointed Michael McDonnell as Executive Vice President and Chief Financial Officer, effective August 15, …

Appointment
shutterstock_244903099

UK Government invests £100m in new COVID-19 vaccine manufacturing site

July 23, 2020
Manufacturing and Production, Research and Development COVID-19, UK, Vaccine, coronavirus

The UK Government’s Department for Business, Energy & Industrial Strategy has revealed a new pledge of an additional £100 million …

News
visor

Face shields did not protect people from a COVID-19 outbreak in Switzerland but masks did, according to health officials

July 23, 2020
Business Services COVID, Pandemic., coronavirus, covid19, pandemic

Health officials in Switzerland are warning against wearing plastic face shields without masks after a recent outbreak at a hotel …

News
winter_mask

Research suggests COVID-19 outcomes are worse in colder months

July 23, 2020
Research and Development COVID-19, coronavirus

A partnership between Chinese and European researchers has argued that the severity of COVID-19 could be worse in colder weather …

News
novavax

Executives at Novavax expected to get big payouts, even if their vaccine fails clinical trials

July 23, 2020
Medical Communications, Sales and Marketing COVID Vaccine, Vaccine, coronavirus

Novavax, one of the leading US firms which is developing a coronavirus vaccine, is set to award executives stock options …

News
parliemant

British pandemic strategy has been an “astonishing” failure, says cross-party parliamentary committee

July 23, 2020
Business Services COVID-19, coronavirus, pandemic

There was an “astonishing” failure of the British government to plan for the economic fallout of a potential pandemic, according …

News
800px-smallpox_vaccine

Pfizer and BioNTech’s COVID-19 vaccine shows promise in another early stage study

July 22, 2020
Research and Development BioNTech, COVID-19, Pfizer, Vaccine, pharma

BioNTech and Pfizer have revealed more promising early data on their lipid nanoparticle formulated, nucleoside-modified messenger RNA vaccine candidate against …

News
fda

FDA sets out guidelines on cannabis derived drugs

July 22, 2020
Research and Development CBD, CBD Oil

The FDA has released their guidelines on the rules companies should follow when developing cannabis derived drugs. The guidelines cover …

News
abbvie_0

AbbVie’s Rinvoq smashes Phase 3 efficacy targets in atopic dermatits

July 22, 2020
Research and Development AbbVie, atopic dermatits, pharma, upadacitinib

AbbVie has lifted the curtain on data from the second Phase 3 trial investigating the efficacy of Rinvoq (upadacitinib) monotherapy …

News
vaccinessssssssssssssssssss_1

US indicts two Chinese hackers for attempting to steal COVID-19 drug and vaccine research

July 22, 2020
Research and Development COVID-19 Vaccines, coronavirus, hacking, vaccines

Two Chinese hackers have been charged in the US with hacking medical companies and stealing hundreds of millions of dollars …

News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

July 22, 2020
Research and Development COVID-19, coronavirus

The COVID-19 news this week once again focuses on vaccines, as the UK has secured early access to 90 million …

News
shutter

Acadia’s pimavanserin falls short at Phase 3 in major depressive disorder

July 21, 2020
Manufacturing and Production, Research and Development Acadia Pharmaceuticals, major depressive disorder, phase 3, trial failure

Acadia Pharmaceuticals has lifted the lid on new Phase 3 for its therapy pimavanserin, revealing that the drug unfortunately failed …

News
vaccinessssssssssssssssssss_1

India begins human trials of its first homegrown coronavirus vaccine

July 21, 2020
Manufacturing and Production COVID, COVID-19, Vaccine, coronavirus

India has begun human trials of its first internally developed vaccine for COVID-19. The Indian Council of Medical Research have …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026